https://mounjaronews.info/daily1.0https://mounjaronews.info/posts/2026-08-04-mounjaro-et-ozempic-quelles-differences-pour-la-perte-de-poi/2026-08-04T09:36:54+01:00weekly0.8Mounjaro Newsfr2026-08-04T09:36:54+01:00Mounjaro et Ozempic : quelles différences pour la perte de poids ?https://mounjaronews.info/posts/2026-08-04-mounjaro-que-disent-vraiment-les-etudes-sur-son-efficacite-c/2026-08-04T09:36:48+01:00weekly0.8Mounjaro Newsfr2026-08-04T09:36:48+01:00Mounjaro : que disent vraiment les études sur son efficacité contre le surpoids ?https://mounjaronews.info/posts/2026-08-04-une-vedette-de-tele-realite-revele-son-traitement-a-base-de-/2026-08-04T09:36:41+01:00weekly0.8Mounjaro Newsfr2026-08-04T09:36:41+01:00Une vedette de télé-réalité révèle son traitement à base de tirzépatide après avoir nié recourir aux injections amincissanteshttps://mounjaronews.info/posts/2026-08-03-is-mounjaro-approved-for-weight-loss-in-2026-results-uses-an/2026-08-03T10:39:18+01:00weekly0.8Mounjaro Newsfr2026-08-03T10:39:18+01:00Le Mounjaro autorisé pour maigrir en 2026 ? Résultats, usages et avis des médecinshttps://mounjaronews.info/posts/2026-08-03-koreans-in-their-20s-and-30s-account-for-over-half-of-mounja/2026-08-03T10:39:10+01:00weekly0.8Mounjaro Newsfr2026-08-03T10:39:10+01:00En Corée du Sud, les moins de 40 ans représentent plus de la moitié des prescriptions de Mounjarohttps://mounjaronews.info/posts/2026-08-03-tirzepatide-weight-loss-the-evidence-based-guide-for-sustain/2026-08-03T10:39:01+01:00weekly0.8Mounjaro Newsfr2026-08-03T10:39:01+01:00Tirzépatide et perte de poids : ce que dit la science pour des résultats durableshttps://mounjaronews.info/posts/2026-08-02-slim-shady-smugglers-eye-big-profits-running-weight-loss-dru/2026-08-02T09:06:47+01:00weekly0.8https://mounjaronews.info/posts/2026-08-02-mounjaro-fda-approval-status-2026-clinical-weight-loss-data-/2026-08-02T09:06:39+01:00weekly0.8https://mounjaronews.info/posts/2026-08-01-coree-du-sud-la-surconsommation-de-medicaments-anti-obesite-/2026-08-01T09:03:15+01:00weekly0.8https://mounjaronews.info/posts/2026-08-01-hair-loss-may-be-an-overlooked-side-effect-of-ozempic-and-mo/2026-08-01T09:03:08+01:00weekly0.8https://mounjaronews.info/posts/2026-08-01-koreans-in-their-20s-and-30s-account-for-over-half-of-mounja/2026-08-01T09:03:00+01:00weekly0.8https://mounjaronews.info/posts/2026-07-31-key-facts-eli-lilly-lly-advances-glp-1-750m-cincinnati-expan/2026-07-31T09:40:58+01:00weekly0.8https://mounjaronews.info/posts/2026-07-31-6-best-affordable-online-tirzepatide-providers-2026/2026-07-31T09:40:50+01:00weekly0.8https://mounjaronews.info/posts/2026-07-31-fda-updates-product-specific-guidelines-for-injectable-pepti/2026-07-31T09:40:42+01:00weekly0.8https://mounjaronews.info/posts/2026-07-30-ozempic-wegovy-mounjaro-zepbound-differences-and-what-the-va/2026-07-30T09:28:26+01:00weekly0.8https://mounjaronews.info/posts/2026-07-30-glp-1-drugs-like-ozempic-mounjaro-may-cause-muscle-loss-with/2026-07-30T09:28:17+01:00weekly0.8https://mounjaronews.info/posts/2026-07-30-which-group-achieves-41-more-weight-loss-on-glp-1s-like-moun/2026-07-30T09:28:09+01:00weekly0.8https://mounjaronews.info/posts/2026-07-29-here-s-how-lly-s-non-glp-1-portfolio-is-poised-ahead-of-q2-e/2026-07-29T09:34:57+01:00weekly0.8https://mounjaronews.info/posts/2026-07-29-dr-roach-physician-orders-mounjaro-for-woman-but-with-a-safe/2026-07-29T09:34:49+01:00weekly0.8https://mounjaronews.info/posts/2026-07-28-are-weight-loss-drugs-covered-by-insurance-plans/2026-07-28T09:33:50+01:00weekly0.8https://mounjaronews.info/posts/2026-07-28-a-case-of-severe-hypercalcemia-in-a-patient-taking-tirzepati/2026-07-28T09:33:40+01:00weekly0.8https://mounjaronews.info/posts/2026-07-27-a-case-of-severe-hypercalcemia-in-a-patient-taking-tirzepati/2026-07-27T10:38:59+01:00weekly0.8https://mounjaronews.info/posts/2026-07-25-combining-tirzepatide-with-niacinamide-potential-benefits-si/2026-07-25T08:58:42+01:00weekly0.8https://mounjaronews.info/posts/2026-07-25-weight-loss-drugs-linked-to-increased-risk-of-hair-loss-rese/2026-07-25T08:58:34+01:00weekly0.8https://mounjaronews.info/posts/2026-07-25-novo-seeks-injunction-to-stop-lilly-s-false-and-misleading-g/2026-07-25T08:58:26+01:00weekly0.8https://mounjaronews.info/posts/2026-07-24-novo-nordisk-sues-eli-lilly-over-zepbound-and-mounjaro-adver/2026-07-24T09:18:23+01:00weekly0.8https://mounjaronews.info/posts/2026-07-24-novo-sues-lilly-claiming-misleading-ads-in-weight-loss-drug-/2026-07-24T09:18:14+01:00weekly0.8https://mounjaronews.info/posts/2026-07-24-ozempic-and-mounjaro-linked-to-a-surprising-hair-loss-risk/2026-07-24T09:18:06+01:00weekly0.8https://mounjaronews.info/posts/2026-07-23-analyst-surprised-by-novo-s-legal-action-against-eli-lilly/2026-07-23T09:22:45+01:00weekly0.8https://mounjaronews.info/posts/2026-07-23-hair-loss-with-glp-1-drugs-is-rare-but-real-studies-find-the/2026-07-23T09:22:37+01:00weekly0.8https://mounjaronews.info/posts/2026-07-23-hair-loss-with-glp-1-drugs-is-rare-but-real-studies-find/2026-07-23T09:22:29+01:00weekly0.8https://mounjaronews.info/posts/2026-07-22-novo-nordisk-sues-eli-lilly-over-zepbound-and-mounjaro-ads-a/2026-07-22T09:24:22+01:00weekly0.8https://mounjaronews.info/posts/2026-07-22-newer-glp-1-medications-may-reduce-alcohol-related-hospitali/2026-07-22T09:24:12+01:00weekly0.8https://mounjaronews.info/posts/2026-07-22-why-novo-nordisk-sued-eli-lilly-over-zepbound-mounjaro-ads-p/2026-07-22T09:24:04+01:00weekly0.8https://mounjaronews.info/posts/2026-07-21-troubling-findings-in-study-of-glp-1-compounders-medpage-tod/2026-07-21T09:24:44+01:00weekly0.8https://mounjaronews.info/posts/2026-07-19-does-stopping-a-glp-1-really-doom-you-to-regain-all-the-weig/2026-07-19T09:03:21+01:00weekly0.8https://mounjaronews.info/posts/2026-07-18-glp-1-weight-loss-drugs-may-lower-the-need-for-knee-replacem/2026-07-18T08:46:47+01:00weekly0.8https://mounjaronews.info/posts/2026-07-18-zepbound-glp-1s-may-raise-frailty-muscle-loss-risk-in-older-/2026-07-18T08:46:38+01:00weekly0.8https://mounjaronews.info/posts/2026-07-18-orforglipron-vs-tirzepatide-what-are-the-major-differences/2026-07-18T08:46:30+01:00weekly0.8https://mounjaronews.info/posts/2026-07-17-people-can-lose-their-zest-for-life-after-starting-glp-1s-do/2026-07-17T09:06:43+01:00weekly0.8https://mounjaronews.info/posts/2026-07-17-compounded-glp-1s-why-doctors-worry-and-the-fda-is-cracking-/2026-07-17T09:06:33+01:00weekly0.8https://mounjaronews.info/posts/2026-07-16-glp-1-fraud-asheville-wellness-owner-charged-with-distributi/2026-07-16T09:10:20+01:00weekly0.8https://mounjaronews.info/posts/2026-07-16-wegovy-and-mounjaro-could-be-used-to-treat-patients-with-eat/2026-07-16T09:10:12+01:00weekly0.8https://mounjaronews.info/posts/2026-07-16-how-to-avoid-fake-weight-loss-injections-in-costa-rica-the-t/2026-07-16T09:10:04+01:00weekly0.8https://mounjaronews.info/posts/2026-07-15-traitements-anti-obesite-les-plus-efficaces-ont-aussi-le-plu/2026-07-15T09:07:35+01:00weekly0.8https://mounjaronews.info/posts/2026-07-15-south-africa-escalates-ozempic-crackdown-as-doctors-risk-los/2026-07-15T09:07:25+01:00weekly0.8https://mounjaronews.info/posts/2026-07-14-tirzepatide-costs-insurance-coverage-savings-tips/2026-07-14T09:02:19+01:00weekly0.8https://mounjaronews.info/posts/2026-07-14-fda-accepts-sandoz-generic-tirzepatide-applications-amid-bio/2026-07-14T09:02:11+01:00weekly0.8https://mounjaronews.info/posts/2026-07-12-weight-loss-jabs-may-create-a-new-kind-of-yo-yo-dieting-medi/2026-07-12T09:00:13+01:00weekly0.8https://mounjaronews.info/posts/2026-07-12-zevay-glp-1-review-2026-could-this-lower-cost-telehealth-opt/2026-07-12T09:00:05+01:00weekly0.8https://mounjaronews.info/posts/2026-07-12-health-canada-approves-mounjaro-tirzepatide-for-use-in-child/2026-07-12T08:59:57+01:00weekly0.8https://mounjaronews.info/posts/2026-07-10-record-numbers-of-americans-are-on-glp-1-drugs-that-s-great-/2026-07-10T10:21:25+01:00weekly0.8https://mounjaronews.info/posts/2026-07-10-south-african-regulators-issue-recall-of-ozempic-copies/2026-07-10T10:21:12+01:00weekly0.8https://mounjaronews.info/posts/2026-07-10-peptron-says-lilly-research-remains-on-track-as-mounjaro-rem/2026-07-10T10:21:03+01:00weekly0.8https://mounjaronews.info/posts/2026-07-09-most-obesity-drugs-do-not-improve-quality-of-life-or-heart-h/2026-07-09T10:22:08+01:00weekly0.8https://mounjaronews.info/posts/2026-07-09-wegovy-and-mounjaro-obesity-drugs-do-not-improve-quality-of-/2026-07-09T10:21:57+01:00weekly0.8https://mounjaronews.info/posts/2026-07-09-why-do-ozempic-and-mounjaro-work-for-some-people-but-not-oth/2026-07-09T10:21:49+01:00weekly0.8https://mounjaronews.info/posts/2026-07-08-sante-canada-approuve-mounjaro-md-tirzepatide-pour-le-traite/2026-07-08T09:24:32+01:00weekly0.8https://mounjaronews.info/posts/2026-07-08-fda-receives-applications-for-generic-mounjaro-zepbound/2026-07-08T09:24:23+01:00weekly0.8https://mounjaronews.info/posts/2026-07-08-health-canada-approves-mounjaro-tirzepatide-for-use-in-child/2026-07-08T09:24:15+01:00weekly0.8https://mounjaronews.info/posts/2026-07-07-the-oral-glp-1-tracker-jefferies-models-71m-us-sales-in-foun/2026-07-07T10:22:55+01:00weekly0.8https://mounjaronews.info/posts/2026-07-07-mounjaro-zepbound-generic-glp-1-drugs-may-soon-be-available/2026-07-07T10:22:46+01:00weekly0.8https://mounjaronews.info/posts/2026-07-06-why-isn-t-there-oral-tirzepatide-what-to-know-forbes-health/2026-07-06T11:25:22+01:00weekly0.8https://mounjaronews.info/posts/2026-07-05-everything-you-need-to-know-about-glp-1s-for-weight-loss-the/2026-07-05T09:39:54+01:00weekly0.8https://mounjaronews.info/posts/2026-07-05-comparing-ozempic-wegovy-and-other-glp-1-drugs/2026-07-05T09:39:46+01:00weekly0.8https://mounjaronews.info/posts/2026-07-04-fda-accepts-sandoz-applications-for-generic-tirzepatide-drug/2026-07-04T09:19:55+01:00weekly0.8https://mounjaronews.info/posts/2026-07-03-rising-use-of-diabetes-drugs-for-weight-loss-raises-health-c/2026-07-03T09:54:33+01:00weekly0.8https://mounjaronews.info/posts/2026-07-03-glp-1s-101-what-the-science-says-about-weight-loss-side-effe/2026-07-03T09:54:23+01:00weekly0.8https://mounjaronews.info/posts/2026-07-03-ex-north-texas-principal-facing-charges-for-allegedly-sellin/2026-07-03T09:54:15+01:00weekly0.8https://mounjaronews.info/posts/2026-07-02-stroke-glp-1s-like-ozempic-mounjaro-may-reduce-cardiovascula/2026-07-02T10:08:14+01:00weekly0.8https://mounjaronews.info/posts/2026-07-02-weight-loss-pills-can-orforglipron-preserve-weight-loss-afte/2026-07-02T10:08:06+01:00weekly0.8https://mounjaronews.info/posts/2026-07-02-us-fda-accepts-sandoz-applications-for-proposed-in-house-dev/2026-07-02T10:07:58+01:00weekly0.8https://mounjaronews.info/posts/2026-06-29-la-fda-s-apprete-a-examiner-les-generiques-de-glp-1-de-sando/2026-06-29T11:56:48+01:00weekly0.8https://mounjaronews.info/posts/2026-06-29-mounjaro-pilot-to-bypass-gp-appointments-in-parts-of-uk-puls/2026-06-29T11:56:39+01:00weekly0.8https://mounjaronews.info/posts/2026-06-29-fda-set-to-review-sandoz-s-generic-glp-1s/2026-06-29T11:56:30+01:00weekly0.8https://mounjaronews.info/posts/2026-06-27-les-medicaments-antiobesite-wegovy-et-mounjaro-seront-rembou/2026-06-27T09:26:55+01:00weekly0.8https://mounjaronews.info/posts/2026-06-27-aglp-1-et-prise-en-charge/2026-06-27T09:26:47+01:00weekly0.8https://mounjaronews.info/posts/2026-06-27-survodutide-le-futur-rival-du-semaglutide-et-du-tirzepatide-/2026-06-27T09:26:40+01:00weekly0.8https://mounjaronews.info/posts/2026-06-26-leerink-releve-son-objectif-de-cours-pour-eli-lilly-en-raiso/2026-06-26T10:21:24+01:00weekly0.8https://mounjaronews.info/posts/2026-06-26-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-agonist-demons/2026-06-26T10:21:16+01:00weekly0.8https://mounjaronews.info/posts/2026-06-26-glp-1s-what-should-you-know-community-reporter/2026-06-26T10:21:08+01:00weekly0.8https://mounjaronews.info/posts/2026-06-25-lilly-s-glp-1-windfall-fuels-m-a-land-grab-across-10-deals-2/2026-06-25T10:13:43+01:00weekly0.8https://mounjaronews.info/posts/2026-06-25-lilly-launches-its-lillydirect-sales-channel-in-the-uk/2026-06-25T10:13:35+01:00weekly0.8https://mounjaronews.info/posts/2026-06-25-clinical-implications-of-mounjaro-tirzepatide-for-breast-can/2026-06-25T10:13:28+01:00weekly0.8https://mounjaronews.info/posts/2026-06-24-big-obesity-bets-and-china-s-rise-fuel-potential-2t-in-2032-/2026-06-24T10:20:38+01:00weekly0.8https://mounjaronews.info/posts/2026-06-24-lilly-s-tirzepatide-will-be-biggest-blockbuster-ever-topping/2026-06-24T10:20:29+01:00weekly0.8https://mounjaronews.info/posts/2026-06-24-what-is-mounjaro-and-does-it-work-better-for-weight-loss-tha/2026-06-24T10:20:19+01:00weekly0.8https://mounjaronews.info/posts/2026-06-23-wegovy-zepbound-guideline-advises-glp-1s-as-first-line-obesi/2026-06-23T10:34:42+01:00weekly0.8https://mounjaronews.info/posts/2026-06-23-7-glp-1-side-effects-to-expect-week-by-week/2026-06-23T10:34:34+01:00weekly0.8https://mounjaronews.info/posts/2026-06-23-weight-loss-is-zepbound-or-wegovy-more-effective/2026-06-23T10:34:25+01:00weekly0.8https://mounjaronews.info/posts/2026-06-21-wegovy-et-mounjaro-le-remboursement-officiellement-acte-mais/2026-06-21T10:27:30+01:00weekly0.8https://mounjaronews.info/posts/2026-06-21-which-glp-1-works-best-new-meta-study-puts-them-head-to-head/2026-06-21T10:27:22+01:00weekly0.8https://mounjaronews.info/posts/2026-06-20-cancer-les-medicaments-comme-ozempic-et-mounjaro-reduiraient/2026-06-20T10:07:47+01:00weekly0.8https://mounjaronews.info/posts/2026-06-20-prise-en-charge-deux-medicaments-contre-l-obesite-rembourses/2026-06-20T10:07:39+01:00weekly0.8https://mounjaronews.info/posts/2026-06-20-what-is-zepbound-does-this-weight-loss-drug-work-better-than/2026-06-20T10:07:32+01:00weekly0.8https://mounjaronews.info/posts/2026-06-19-obesite-prise-en-charge-de-wegovy-et-mounjaro-a-partir-du-15/2026-06-19T11:19:13+01:00weekly0.8https://mounjaronews.info/posts/2026-06-19-appetite-for-ozempic-wanes-forbes-india/2026-06-19T11:19:05+01:00weekly0.8https://mounjaronews.info/posts/2026-06-19-compounded-tirzepatide-vs-mounjaro-what-s-the-difference/2026-06-19T11:18:57+01:00weekly0.8https://mounjaronews.info/posts/2026-06-18-eli-lilly-presente-des-resultats-prometteurs-pour-un-nouvel-/2026-06-18T11:07:38+01:00weekly0.8https://mounjaronews.info/posts/2026-06-18-tirzepatide-vs-semaglutide-which-is-more-effective-in-the-re/2026-06-18T11:07:30+01:00weekly0.8https://mounjaronews.info/posts/2026-06-18-most-people-who-stop-glp-1-drugs-like-ozempic-eventually-ret/2026-06-18T11:07:19+01:00weekly0.8https://mounjaronews.info/posts/2026-06-17-behavioral-modifications-like-goal-setting-could-lead-to-gre/2026-06-17T11:44:25+01:00weekly0.8https://mounjaronews.info/posts/2026-06-17-tirzepatide-outperforms-semaglutide-for-real-world-weight-lo/2026-06-17T11:44:16+01:00weekly0.8https://mounjaronews.info/posts/2026-06-17-tirzepatide-outperformed-semaglutide-weight-loss-drug-result/2026-06-17T11:44:08+01:00weekly0.8https://mounjaronews.info/posts/2026-06-16-behavioral-modifications-like-goal-setting-could-lead-to-gre/2026-06-16T12:10:30+01:00weekly0.8https://mounjaronews.info/posts/2026-06-16-people-taking-glp-1-weight-loss-drugs-like-ozempic-started-m/2026-06-16T12:10:23+01:00weekly0.8https://mounjaronews.info/posts/2026-06-16-how-tirzepatide-works-for-weight-loss-understanding-tirzepat/2026-06-16T12:10:14+01:00weekly0.8https://mounjaronews.info/posts/2026-06-15-which-glp-1-medication-is-most-effective-for-weight-loss-uga/2026-06-15T13:10:24+01:00weekly0.8https://mounjaronews.info/posts/2026-06-14-glp-1s-appear-to-protect-against-cancer-researchers-are-tryi/2026-06-14T10:22:44+01:00weekly0.8https://mounjaronews.info/posts/2026-06-13-can-mounjaro-cause-constipation-yes-try-this-for-relief/2026-06-13T09:54:44+01:00weekly0.8https://mounjaronews.info/posts/2026-06-13-apitegromab-for-lean-mass-preservation-during-tirzepatide-in/2026-06-13T09:54:37+01:00weekly0.8https://mounjaronews.info/posts/2026-06-13-new-drug-retatrutide-shows-benefits-for-diabetes-and-weight-/2026-06-13T09:54:30+01:00weekly0.8https://mounjaronews.info/posts/2026-06-12-les-a-glp-1-favorisent-ils-l-anhedonie-journal-international/2026-06-12T10:59:09+01:00weekly0.8https://mounjaronews.info/posts/2026-06-12-is-there-anything-glp-1-agonist-drugs-cannot-do/2026-06-12T10:59:02+01:00weekly0.8https://mounjaronews.info/posts/2026-06-12-acute-small-bowel-obstruction-induced-by-tirzepatide-mounjar/2026-06-12T10:58:53+01:00weekly0.8https://mounjaronews.info/posts/2026-06-11-millions-of-older-americans-soon-could-get-popular-weight-lo/2026-06-11T11:20:59+01:00weekly0.8https://mounjaronews.info/posts/2026-06-11-large-study-links-glp-1s-to-lower-risk-of-multiple-cancers-m/2026-06-11T11:20:49+01:00weekly0.8https://mounjaronews.info/posts/2026-06-11-japan-grapples-with-off-label-mounjaro-trade-for-weight-loss/2026-06-11T11:20:42+01:00weekly0.8https://mounjaronews.info/posts/2026-06-10-eli-lilly-and-novo-nordisk-set-to-share-obesity-drug-market-/2026-06-10T10:54:04+01:00weekly0.8https://mounjaronews.info/posts/2026-06-10-mounjaro-costs-insurance-coverage-savings-tips/2026-06-10T10:53:55+01:00weekly0.8https://mounjaronews.info/posts/2026-06-10-thinness-equals-beauty-mounjaro-misuse-among-women-sparks-he/2026-06-10T10:53:45+01:00weekly0.8https://mounjaronews.info/posts/2026-06-09-novo-nordisk-real-world-data-supports-ozempic-against-lly-s-/2026-06-09T10:32:43+01:00weekly0.8https://mounjaronews.info/posts/2026-06-09-use-of-glp-1-drugs-early-in-pregnancy-should-not-cause-alarm/2026-06-09T10:32:35+01:00weekly0.8https://mounjaronews.info/posts/2026-06-09-muscle-growth-drug-could-reduce-loss-of-lean-tissue-when-usi/2026-06-09T10:32:27+01:00weekly0.8https://mounjaronews.info/posts/2026-06-08-ada26-pfizer-builds-momentum-for-metsera-glp-1-bet-amid-slew/2026-06-08T11:54:07+01:00weekly0.8https://mounjaronews.info/posts/2026-06-08-column-mounjaro-s-reimbursement-failure-whose-responsibility/2026-06-08T11:53:59+01:00weekly0.8https://mounjaronews.info/posts/2026-06-08-how-long-has-mounjaro-been-on-the-market/2026-06-08T11:53:51+01:00weekly0.8https://mounjaronews.info/posts/2026-06-07-the-next-goal-for-weight-loss-drugs-fewer-injections-nbc-new/2026-06-07T09:58:06+01:00weekly0.8https://mounjaronews.info/posts/2026-06-07-ozempic-and-similar-weight-loss-drugs-linked-to-30-lower-bre/2026-06-07T09:57:58+01:00weekly0.8https://mounjaronews.info/posts/2026-06-07-no-increased-retinopathy-risk-seen-with-tirzepatide/2026-06-07T09:57:50+01:00weekly0.8https://mounjaronews.info/posts/2026-06-06-ozempic-wegovy-ou-mounjaro-des-problemes-de-pancreas-rapport/2026-06-06T09:23:16+01:00weekly0.8https://mounjaronews.info/posts/2026-06-06-traitements-de-l-obesite-un-remboursement-partiel-qui-pose-q/2026-06-06T09:23:09+01:00weekly0.8https://mounjaronews.info/posts/2026-06-06-mounjaro-tirzepatide-side-effects-risks-fda-warnings/2026-06-06T09:23:00+01:00weekly0.8https://mounjaronews.info/posts/2026-06-05-traitements-antiobesite-les-laboratoires-novo-nordisk-et-eli/2026-06-05T10:44:12+01:00weekly0.8https://mounjaronews.info/posts/2026-06-05-obesite-le-tirzepatide-devant-le-semaglutide-dans-la-prise-e/2026-06-05T10:44:04+01:00weekly0.8https://mounjaronews.info/posts/2026-06-05-medicaments-anti-obesite-fonctionnement-suivi-medical-et-con/2026-06-05T10:43:57+01:00weekly0.8https://mounjaronews.info/posts/2026-06-04-weight-loss-drugs-risk-widening-health-inequalities-warn-res/2026-06-04T10:37:16+01:00weekly0.8https://mounjaronews.info/posts/2026-06-04-weight-loss-jabs-northampton-raid-finds-first-illegal-own-br/2026-06-04T10:37:08+01:00weekly0.8https://mounjaronews.info/posts/2026-06-04-lilly-korea-to-launch-higher-dose-mounjaro-pens-on-june-10/2026-06-04T10:36:59+01:00weekly0.8https://mounjaronews.info/posts/2026-06-03-mounjaro-efficacite-effets-secondaires-et-avis-medical/2026-06-03T11:54:12+01:00weekly0.8https://mounjaronews.info/posts/2026-06-03-weight-loss-jabs-slash-cancer-risk-and-boost-survival-rates-/2026-06-03T11:54:04+01:00weekly0.8https://mounjaronews.info/posts/2026-06-03-weight-loss-drugs-may-prevent-thousands-of-knee-replacements/2026-06-03T11:53:57+01:00weekly0.8https://mounjaronews.info/posts/2026-06-02-the-face-of-prescription-fat-loss-treatments-who-are-the-bes/2026-06-02T11:15:46+01:00weekly0.8https://mounjaronews.info/posts/2026-06-02-weight-loss-drugs-and-the-eye-worry-this-study-points-to-a-s/2026-06-02T11:15:37+01:00weekly0.8https://mounjaronews.info/posts/2026-06-02-weight-loss-drugs-could-widen-health-inequalities-without-nu/2026-06-02T11:15:28+01:00weekly0.8https://mounjaronews.info/posts/2026-06-01-wegovy-et-mounjaro-rembourses-un-tournant-sous-conditions-po/2026-06-01T12:33:35+01:00weekly0.8https://mounjaronews.info/posts/2026-06-01-ozempic-may-be-reshaping-the-brain-scientists-say-the-washin/2026-06-01T12:33:28+01:00weekly0.8https://mounjaronews.info/posts/2026-05-31-medicaments-pour-maigrir-rembourses-des-le-15-juin-lequel-es/2026-05-31T09:45:56+01:00weekly0.8https://mounjaronews.info/posts/2026-05-31-eli-lilly-presente-des-resultats-prometteurs-pour-un-nouvel-/2026-05-31T09:45:48+01:00weekly0.8https://mounjaronews.info/posts/2026-05-30-weight-loss-drug-retatrutide-use-requires-strict-supervision/2026-05-30T09:13:09+01:00weekly0.8https://mounjaronews.info/posts/2026-05-30-pharma-roundup-mounjaro-shows-advantages-in-type-2-diabetes-/2026-05-30T09:13:01+01:00weekly0.8https://mounjaronews.info/posts/2026-05-30-lilly-s-mounjaro-tops-other-glp-1s-for-some-type-2-diabetes-/2026-05-30T09:12:53+01:00weekly0.8https://mounjaronews.info/posts/2026-05-29-10-ozempic-alternatives-for-2026/2026-05-29T10:43:25+01:00weekly0.8https://mounjaronews.info/posts/2026-05-29-france-first-eu-country-to-cover-obesity-drugs/2026-05-29T10:43:18+01:00weekly0.8https://mounjaronews.info/posts/2026-05-29-lilly-to-present-new-data-on-foundayo-mounjaro-and-retatruti/2026-05-29T10:43:10+01:00weekly0.8https://mounjaronews.info/posts/2026-05-28-eli-lilly-wins-appeal-against-misleading-advertising-by-gene/2026-05-28T10:52:44+01:00weekly0.8https://mounjaronews.info/posts/2026-05-28-tirzepatide-superior-to-intensified-conventional-care-for-ea/2026-05-28T10:52:35+01:00weekly0.8https://mounjaronews.info/posts/2026-05-27-mounjaro-for-weight-loss-results-side-effects-and-how-it-wor/2026-05-27T10:53:34+01:00weekly0.8https://mounjaronews.info/posts/2026-05-25-victoza-vs-mounjaro-7-differences-to-know/2026-05-25T11:07:45+01:00weekly0.8https://mounjaronews.info/posts/2026-05-24-obesite-mounjaro-le-medicament-qui-fait-maigrir-bientot-remb/2026-05-24T09:20:09+01:00weekly0.8https://mounjaronews.info/posts/2026-05-24-zepbound-vs-wegovy-differences-between-weight-loss-medicatio/2026-05-24T09:20:02+01:00weekly0.8https://mounjaronews.info/posts/2026-05-23-case-report-small-bowel-obstruction-after-starting-tirzepati/2026-05-23T09:01:04+01:00weekly0.8https://mounjaronews.info/posts/2026-05-23-tirzepatide-yields-early-weight-loss-later-plateau/2026-05-23T09:00:55+01:00weekly0.8https://mounjaronews.info/posts/2026-05-23-mounjaro-side-effects-common-serious-fda-warnings/2026-05-23T09:00:46+01:00weekly0.8https://mounjaronews.info/posts/2026-05-22-eli-lilly-s-next-gen-obesity-drug-beats-ozempic-and-mounjaro/2026-05-22T10:22:21+01:00weekly0.8https://mounjaronews.info/posts/2026-05-22-retatrutide-helped-adults-with-obesity-lose-up-to-30-percent/2026-05-22T10:22:13+01:00weekly0.8https://mounjaronews.info/posts/2026-05-22-mounjaro-naion-lawsuit-claims-side-effects-led-to-permanent-/2026-05-22T10:22:04+01:00weekly0.8https://mounjaronews.info/posts/2026-05-21-rhonjs-jennifer-aydin-from-denying-ozempic-to-admitting-moun/2026-05-21T10:38:30+01:00weekly0.8https://mounjaronews.info/posts/2026-05-20-glp-1-drugs-linked-to-significant-boost-in-testosterone-leve/2026-05-20T10:23:31+01:00weekly0.8https://mounjaronews.info/posts/2026-05-20-ozari-health-launches-nationwide-telehealth-platform-for-com/2026-05-20T10:23:24+01:00weekly0.8https://mounjaronews.info/posts/2026-05-20-people-who-lost-the-most-weight-on-ozempic-saw-huge-health-b/2026-05-20T10:23:16+01:00weekly0.8https://mounjaronews.info/posts/2026-05-19-the-mistake-that-worsens-the-side-effects-of-weight-loss-inj/2026-05-19T10:35:40+01:00weekly0.8https://mounjaronews.info/posts/2026-05-19-tirzepatide-mounjaro-for-the-treatment-of-type-2-diabetes-me/2026-05-19T10:35:31+01:00weekly0.8https://mounjaronews.info/posts/2026-05-19-insulin-deprescribing-utilizing-continuous-glucose-monitorin/2026-05-19T10:35:24+01:00weekly0.8https://mounjaronews.info/posts/2026-05-18-mounjaro-vs-ozempic-differences-weight-loss-more/2026-05-18T11:04:55+01:00weekly0.8https://mounjaronews.info/posts/2026-05-17-tirzepatide-side-effects-blood-clots-gastroparesis-more-motl/2026-05-17T09:02:51+01:00weekly0.8https://mounjaronews.info/posts/2026-05-17-mounjaro-for-weight-loss-safety-side-effects-and-more/2026-05-17T09:02:43+01:00weekly0.8https://mounjaronews.info/posts/2026-05-16-can-you-take-mounjaro-and-metformin-together/2026-05-16T08:46:29+01:00weekly0.8https://mounjaronews.info/posts/2026-05-16-beyond-mounjaro-korean-drugmakers-chase-monthly-obesity-shot/2026-05-16T08:46:21+01:00weekly0.8https://mounjaronews.info/posts/2026-05-16-ketoacidosis-risk-in-non-diabetic-patients-using-semaglutide/2026-05-16T08:46:13+01:00weekly0.8https://mounjaronews.info/posts/2026-05-15-barclays-releve-l-objectif-de-cours-d-eli-lilly-sur-fond-de-/2026-05-15T09:45:15+01:00weekly0.8https://mounjaronews.info/posts/2026-05-15-japan-slashes-mounjaro-price-25-readies-revised-price-cut-sy/2026-05-15T09:45:07+01:00weekly0.8https://mounjaronews.info/posts/2026-05-14-fda-proposes-to-exclude-glp-1s-from-503b-bulk-list-drug-topi/2026-05-14T09:31:56+01:00weekly0.8https://mounjaronews.info/posts/2026-05-14-lilly-s-foundayo-and-lower-dose-zepbound-helped-people-maint/2026-05-14T09:31:48+01:00weekly0.8https://mounjaronews.info/posts/2026-05-14-how-do-weight-loss-drugs-like-mounjaro-and-wegovy-work/2026-05-14T09:31:40+01:00weekly0.8https://mounjaronews.info/posts/2026-05-13-daily-weight-loss-pills-could-spell-end-of-diabetes-the-time/2026-05-13T09:42:55+01:00weekly0.8https://mounjaronews.info/posts/2026-05-13-daily-pill-can-help-people-maintain-weight-loss-after-they-c/2026-05-13T09:42:48+01:00weekly0.8https://mounjaronews.info/posts/2026-05-13-daily-pill-to-help-keep-weight-off-after-stopping-obesity-ja/2026-05-13T09:42:40+01:00weekly0.8https://mounjaronews.info/posts/2026-05-12-benefits-of-starting-mounjaro-and-ozempic-early-making-sense/2026-05-12T09:34:58+01:00weekly0.8https://mounjaronews.info/posts/2026-05-12-how-to-get-tirzepatide-eligibility-criteria-cost-and-more/2026-05-12T09:34:50+01:00weekly0.8https://mounjaronews.info/posts/2026-05-12-tirzepatide-mounjaro-type-2-diabetes-drug-guide-everyday-hea/2026-05-12T09:34:42+01:00weekly0.8https://mounjaronews.info/posts/2026-05-11-does-mounjaro-help-with-erectile-dysfunction-portal-cnj/2026-05-11T10:36:04+01:00weekly0.8https://mounjaronews.info/posts/2026-05-11-mounjaro-remains-number-one-in-india-as-torrent-captures-38-/2026-05-11T10:35:56+01:00weekly0.8https://mounjaronews.info/posts/2026-05-11-eli-lilly-s-mounjaro-surpasses-merck-s-keytruda-as-best-sell/2026-05-11T10:35:50+01:00weekly0.8https://mounjaronews.info/posts/2026-05-10-can-mounjaro-help-with-erectile-dysfunction-portal-cnj/2026-05-10T08:51:07+01:00weekly0.8https://mounjaronews.info/posts/2026-05-10-eli-lilly-s-mounjaro-overtakes-keytruda-as-top-selling-drug/2026-05-10T08:51:00+01:00weekly0.8https://mounjaronews.info/posts/2026-05-10-fda-moves-to-remove-glp-1-medications-from-503b-bulks-list-m/2026-05-10T08:50:52+01:00weekly0.8https://mounjaronews.info/posts/2026-05-09-eli-lilly-rises-on-fda-compounding-proposal/2026-05-09T08:25:20+01:00weekly0.8https://mounjaronews.info/posts/2026-05-09-mounjaro-dethrones-keytruda-as-top-selling-global-drug/2026-05-09T08:25:12+01:00weekly0.8https://mounjaronews.info/posts/2026-05-09-stars-who-ve-spoken-about-ozempic-and-what-they-ve-said/2026-05-09T08:25:06+01:00weekly0.8https://mounjaronews.info/posts/2026-05-08-eli-lilly-s-mounjaro-becomes-world-s-top-selling-drug-the-bu/2026-05-08T08:20:17+01:00weekly0.8https://mounjaronews.info/posts/2026-05-08-lilly-s-mounjaro-becomes-world-s-best-selling-drug-global-co/2026-05-08T08:20:09+01:00weekly0.8https://mounjaronews.info/posts/2026-05-08-mounjaro-sales-exceed-keytruda-in-q1-2026-tirzepatide-sales-/2026-05-08T08:20:01+01:00weekly0.8https://mounjaronews.info/posts/2026-05-07-dual-incretin-agonists-market-size-share-growth-report-2034-/2026-05-07T09:28:53+01:00weekly0.8https://mounjaronews.info/posts/2026-05-07-lilly-s-mounjaro-overtakes-keytruda-as-world-s-top-selling-d/2026-05-07T09:28:45+01:00weekly0.8https://mounjaronews.info/posts/2026-05-07-lly-vs-novo-nordisk-2026-glp-1-stocks-compared/2026-05-07T09:28:37+01:00weekly0.8https://mounjaronews.info/posts/2026-05-06-tirzepatide-tied-to-less-mortality-and-aes-than-semaglutide/2026-05-06T09:21:27+01:00weekly0.8https://mounjaronews.info/posts/2026-05-06-novo-nordisk-buoyed-by-outperforming-oral-wegovy-in-q1/2026-05-06T09:21:18+01:00weekly0.8https://mounjaronews.info/posts/2026-05-06-glp-1-drug-savings-a-complete-guide-for-how-to-save-on-ozemp/2026-05-06T09:21:10+01:00weekly0.8https://mounjaronews.info/posts/2026-05-05-france-fines-novo-nordisk-and-eli-lilly-over-ads-for-anti-ob/2026-05-05T09:06:04+01:00weekly0.8https://mounjaronews.info/posts/2026-05-05-next-gen-glp-1-leads-to-16-more-weight-loss-is-it-better-tha/2026-05-05T09:05:53+01:00weekly0.8https://mounjaronews.info/posts/2026-05-05-obesity-meds-push-pharma-returns-higher-overtaking-oncology-/2026-05-05T09:05:43+01:00weekly0.8https://mounjaronews.info/posts/2026-05-04-lilly-lowers-the-price-of-zepbound-tirzepatide-single-dose-v/2026-05-04T09:15:19+01:00weekly0.8https://mounjaronews.info/posts/2026-05-04-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/2026-05-04T09:15:11+01:00weekly0.8https://mounjaronews.info/posts/2026-05-03-eli-lilly-stock-jumps-on-earnings-beat-as-zepbound-and-mounj/2026-05-03T08:44:44+01:00weekly0.8https://mounjaronews.info/posts/2026-05-03-fda-moves-to-permanently-close-the-door-on-compounded-glp-1s/2026-05-03T08:44:36+01:00weekly0.8https://mounjaronews.info/posts/2026-05-02-price-pressure-on-weight-loss-drugs-slows-eli-lilly-s-growth/2026-05-02T08:20:09+01:00weekly0.8https://mounjaronews.info/posts/2026-05-02-fda-proposes-excluding-novo-lilly-weight-loss-drugs-from-bul/2026-05-02T08:20:01+01:00weekly0.8https://mounjaronews.info/posts/2026-05-02-us-could-spend-1-trillion-on-medications-on-top-weight-loss-/2026-05-02T08:19:53+01:00weekly0.8https://mounjaronews.info/posts/2026-05-01-fda-wants-to-limit-knockoff-versions-of-weight-loss-drugs-li/2026-05-01T08:58:45+01:00weekly0.8https://mounjaronews.info/posts/2026-05-01-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/2026-05-01T08:58:37+01:00weekly0.8https://mounjaronews.info/posts/2026-05-01-mounjaro-vs-ozempic-what-s-the-difference/2026-05-01T08:58:27+01:00weekly0.8https://mounjaronews.info/posts/2026-04-30-tirzepatide-une-protection-cardiaque-inattendue-pour-ce-medi/2026-04-30T09:09:44+01:00weekly0.8https://mounjaronews.info/posts/2026-04-30-retatrutide-vs-tirzepatide-how-do-they-compare/2026-04-30T09:09:36+01:00weekly0.8https://mounjaronews.info/posts/2026-04-29-new-research-reveals-possible-hidden-side-effects-of-glp-1-d/2026-04-29T09:07:39+01:00weekly0.8https://mounjaronews.info/posts/2026-04-29-system-is-broken-mounjaro-won-t-be-listed-on-pbs-in-stand-of/2026-04-29T09:07:31+01:00weekly0.8https://mounjaronews.info/posts/2026-04-29-lly-earnings-glp-1-mounjaro-zepbound-read-through-for-your-p/2026-04-29T09:07:23+01:00weekly0.8https://mounjaronews.info/posts/2026-04-28-newsgp-mounjaro-manufacturer-rejects-pbs-recommendation-roya/2026-04-28T09:18:52+01:00weekly0.8https://mounjaronews.info/posts/2026-04-28-how-to-get-mounjaro-eligibility-criteria-and-where-to-buy/2026-04-28T09:18:44+01:00weekly0.8https://mounjaronews.info/posts/2026-04-28-glp-1-drugs-ozempic-preserves-muscle-mass-better-than-mounja/2026-04-28T09:18:37+01:00weekly0.8https://mounjaronews.info/posts/2026-04-27-popular-weight-loss-drug-may-cut-heart-attack-risk-by-54-new/2026-04-27T09:19:39+01:00weekly0.8https://mounjaronews.info/posts/2026-04-26-fake-mounjaro-row-accused-had-his-own-brand-toneup-the-times/2026-04-26T08:14:31+01:00weekly0.8https://mounjaronews.info/posts/2026-04-26-maker-of-mounjaro-warns-of-dangerous-chemical-reactions-in-k/2026-04-26T08:14:23+01:00weekly0.8https://mounjaronews.info/posts/2026-04-26-simple-metabolic-reset-found-to-prevent-weight-rebound-after/2026-04-26T08:14:15+01:00weekly0.8https://mounjaronews.info/posts/2026-04-25-the-best-glp-1-drug-on-the-market-is-even-better-than-we-kne/2026-04-25T08:04:03+01:00weekly0.8https://mounjaronews.info/posts/2026-04-25-popular-weight-loss-drug-linked-to-key-benefits-for-patients/2026-04-25T08:03:55+01:00weekly0.8https://mounjaronews.info/posts/2026-04-25-mounjaro-zepbound-lowers-risk-of-cardiovascular-death-by-62/2026-04-25T08:03:47+01:00weekly0.8https://mounjaronews.info/posts/2026-04-24-fake-mounjaro-probe-expands-beyond-ncr-after-seized-stock-tr/2026-04-24T08:58:54+01:00weekly0.8https://mounjaronews.info/posts/2026-04-24-simple-metabolic-reset-found-to-prevent-weight-rebound-after/2026-04-24T08:58:44+01:00weekly0.8https://mounjaronews.info/posts/2026-04-24-skinnyrx-glp-1-claims-evaluated-review-semaglutide-tirzepati/2026-04-24T08:58:36+01:00weekly0.8https://mounjaronews.info/posts/2026-04-23-fda-issues-warning-letter-after-glp-1-manufacturer-refuses-i/2026-04-23T08:51:18+01:00weekly0.8https://mounjaronews.info/posts/2026-04-23-bdcda-issues-advisory-to-trade-fraternity-on-mounjaro-kwikpe/2026-04-23T08:51:10+01:00weekly0.8https://mounjaronews.info/posts/2026-04-23-lilly-s-suit-against-mounjaro-copies-advances-in-second-atte/2026-04-23T08:51:01+01:00weekly0.8https://mounjaronews.info/posts/2026-04-22-glp-1s-and-muscle-loss-ozempic-personality-acromegaly-and-ca/2026-04-22T08:28:19+01:00weekly0.8https://mounjaronews.info/posts/2026-04-22-eli-lilly-can-proceed-with-lawsuit-against-telehealth-seller/2026-04-22T08:28:09+01:00weekly0.8https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-injections-racket-busted-in-gurugram-flat-two-/2026-04-21T08:51:29+01:00weekly0.8https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-worth-rs-56-lakh-seized-in-gurugram-what-it-ca/2026-04-21T08:51:21+01:00weekly0.8https://mounjaronews.info/posts/2026-04-20-resultats-de-eli-lilly-les-ventes-internationales-de-tirzepa/2026-04-20T09:06:35+01:00weekly0.8https://mounjaronews.info/posts/2026-04-20-rs-70-00-000-worth-fake-mounjaro-injections-seized-in-gurgao/2026-04-20T09:06:27+01:00weekly0.8https://mounjaronews.info/posts/2026-04-20-surmount-5-trial-tirzepatide-vs-semaglutide-in-obesity-manag/2026-04-20T09:06:19+01:00weekly0.8https://mounjaronews.info/posts/2026-04-19-l-ansm-muscle-son-jeu-face-a-la-vente-en-ligne-d-analogues-d/2026-04-19T08:05:20+01:00weekly0.8https://mounjaronews.info/posts/2026-04-19-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/2026-04-19T08:05:11+01:00weekly0.8https://mounjaronews.info/posts/2026-04-19-public-health-plans-should-cover-mounjaro-for-type-2-diabete/2026-04-19T08:05:02+01:00weekly0.8https://mounjaronews.info/posts/2026-04-18-une-etude-revele-que-les-medicaments-amaigrissants-de-novo-p/2026-04-18T07:58:34+01:00weekly0.8https://mounjaronews.info/posts/2026-04-18-study-looks-into-which-weight-loss-drug-makes-you-lose-the-m/2026-04-18T07:58:26+01:00weekly0.8https://mounjaronews.info/posts/2026-04-18-can-ozempic-and-other-glp-1-drugs-reverse-type-2-diabetes-ev/2026-04-18T07:58:17+01:00weekly0.8https://mounjaronews.info/posts/2026-04-17-what-happens-when-you-stop-ozempic-or-mounjaro-new-study-rev/2026-04-17T08:25:31+01:00weekly0.8https://mounjaronews.info/posts/2026-04-17-novo-weight-loss-drug-may-preserve-lean-body-mass-better-tha/2026-04-17T08:25:23+01:00weekly0.8https://mounjaronews.info/posts/2026-04-17-ozempic-might-preserve-lean-body-mass-better-than-mounjaro-s/2026-04-17T08:25:16+01:00weekly0.8https://mounjaronews.info/posts/2026-04-16-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/2026-04-16T08:26:08+01:00weekly0.8https://mounjaronews.info/posts/2026-04-16-the-glp-1-era-how-weight-loss-medications-are-rewriting-our-/2026-04-16T08:25:59+01:00weekly0.8https://mounjaronews.info/posts/2026-04-16-glp-1s-are-busting-employer-budgets-some-are-getting-creativ/2026-04-16T08:25:50+01:00weekly0.8https://mounjaronews.info/posts/2026-04-15-popular-weight-loss-medications-linked-to-hidden-side-effect/2026-04-15T08:26:57+01:00weekly0.8https://mounjaronews.info/posts/2026-04-15-generics-play-an-important-role-eli-lilly-on-glp-1-competiti/2026-04-15T08:26:49+01:00weekly0.8https://mounjaronews.info/posts/2026-04-15-mounjaro-approved-for-use-in-children-in-uk-in-significant-a/2026-04-15T08:26:41+01:00weekly0.8https://mounjaronews.info/posts/2026-04-14-thinking-about-a-glp-1-drug-your-genetics-might-determine-ho/2026-04-14T08:24:59+01:00weekly0.8https://mounjaronews.info/posts/2026-04-14-why-some-people-lose-more-weight-on-glp-1-drugs/2026-04-14T08:24:51+01:00weekly0.8https://mounjaronews.info/posts/2026-04-13-cheaper-generics-capture-20-of-weight-loss-mkt-the-times-of-/2026-04-13T09:00:00+01:00weekly0.8https://mounjaronews.info/posts/2026-04-13-not-losing-weight-on-mounjaro-or-ozempic-your-genes-could-be/2026-04-13T08:59:51+01:00weekly0.8https://mounjaronews.info/posts/2026-04-13-ozempic-vs-mounjaro-what-india-s-first-real-world-study-says/2026-04-13T08:59:43+01:00weekly0.8https://mounjaronews.info/posts/2026-04-12-health-rounds-variations-genetiques-liees-a-la-perte-de-poid/2026-04-12T08:01:48+01:00weekly0.8https://mounjaronews.info/posts/2026-04-12-mounjaro-monthly-sales-drop-for-first-time-in-march-semaglut/2026-04-12T08:01:42+01:00weekly0.8https://mounjaronews.info/posts/2026-04-11-unlocking-the-genetics-of-glp-1-medications-why-your-dna-mat/2026-04-11T07:48:06+01:00weekly0.8https://mounjaronews.info/posts/2026-04-11-pharma-50-keytruda-holds-the-top-brand-slot-but-tirzepatide-/2026-04-11T07:47:58+01:00weekly0.8https://mounjaronews.info/posts/2026-04-11-glp-1-weight-loss-side-effects-linked-to-genetic-variations/2026-04-11T07:47:49+01:00weekly0.8https://mounjaronews.info/posts/2026-04-10-evidence-excitement-in-the-moment-with-a-glp-1-expert-uw-med/2026-04-10T08:20:37+01:00weekly0.8https://mounjaronews.info/posts/2026-04-10-tirzepatide-outperforms-dulaglutide-on-cardiorenal-outcomes-/2026-04-10T08:20:27+01:00weekly0.8https://mounjaronews.info/posts/2026-04-10-pharmacists-play-central-role-in-optimizing-tirzepatide-use-/2026-04-10T08:20:17+01:00weekly0.8https://mounjaronews.info/posts/2026-04-09-ozempic-weight-loss-success-varies-by-dna-neuroscience-news/2026-04-09T08:19:24+01:00weekly0.8https://mounjaronews.info/posts/2026-04-09-if-you-aren-t-losing-weight-with-glp-1-drugs-this-may-be-one/2026-04-09T08:19:16+01:00weekly0.8https://mounjaronews.info/posts/2026-04-09-weight-loss-drugs-who-benefits-most-and-why/2026-04-09T08:19:08+01:00weekly0.8https://mounjaronews.info/posts/2026-04-08-mounjaro-slimming-syringe-reuters-connect/2026-04-08T08:12:01+01:00weekly0.8https://mounjaronews.info/posts/2026-04-08-weight-loss-after-tirzepatide-varies-by-prior-weight-change/2026-04-08T08:11:53+01:00weekly0.8https://mounjaronews.info/posts/2026-04-07-9-mounjaro-alternatives-for-weight-loss-and-diabetes/2026-04-07T08:11:39+01:00weekly0.8https://mounjaronews.info/posts/2026-04-07-can-mounjaro-make-birth-control-less-effective-medshadow-fou/2026-04-07T08:11:30+01:00weekly0.8https://mounjaronews.info/posts/2026-04-07-scientists-uncover-new-metabolic-effects-beyond-weight-loss-/2026-04-07T08:11:23+01:00weekly0.8https://mounjaronews.info/posts/2026-04-06-actualite-analogues-du-glp-1-indiques-dans-le-traitement-de-/2026-04-06T08:21:48+01:00weekly0.8https://mounjaronews.info/posts/2026-04-06-9-foundayo-orforglipron-side-effects-you-should-know-about/2026-04-06T08:21:39+01:00weekly0.8https://mounjaronews.info/posts/2026-04-06-mounjaro-slimming-syringe-reuters-connect/2026-04-06T08:21:31+01:00weekly0.8https://mounjaronews.info/posts/2026-04-05-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/2026-04-05T07:53:40+01:00weekly0.8https://mounjaronews.info/posts/2026-04-04-joi-blokes-compounded-glp-1-review-2026-semaglutide-tirzepat/2026-04-04T07:47:30+01:00weekly0.8https://mounjaronews.info/posts/2026-04-04-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/2026-04-04T07:47:21+01:00weekly0.8https://mounjaronews.info/posts/2026-04-03-fda-approves-foundayo-eli-lilly-s-new-glp-1-obesity-pill-liv/2026-04-03T08:01:08+01:00weekly0.8https://mounjaronews.info/posts/2026-04-03-tirzepatide-effective-despite-weight-inducing-meds/2026-04-03T08:00:59+01:00weekly0.8https://mounjaronews.info/posts/2026-04-02-a-second-weight-loss-pill-just-hit-the-market-here-s-how-it-/2026-04-02T08:05:45+01:00weekly0.8https://mounjaronews.info/posts/2026-04-02-with-an-fda-nod-lilly-s-oral-glp-1-enters-the-obesity-ring-a/2026-04-02T08:05:36+01:00weekly0.8https://mounjaronews.info/posts/2026-04-02-fda-approves-eli-lilly-s-obesity-pill-foundayo-time-magazine/2026-04-02T08:05:28+01:00weekly0.8https://mounjaronews.info/posts/2026-04-01-cardiovascular-outcomes-with-tirzepatide-versus-dulaglutide-/2026-04-01T08:14:44+01:00weekly0.8https://mounjaronews.info/posts/2026-03-31-beyond-diabetes-control-tirzepatide-boosts-quality-of-life/2026-03-31T08:07:03+01:00weekly0.8https://mounjaronews.info/posts/2026-03-30-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/2026-03-30T08:21:06+01:00weekly0.8https://mounjaronews.info/posts/2026-03-30-allurion-announces-partnership-to-offer-combination-therapy-/2026-03-30T08:20:57+01:00weekly0.8https://mounjaronews.info/posts/2026-03-30-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/2026-03-30T08:20:49+01:00weekly0.8https://mounjaronews.info/posts/2026-03-28-opinion-taking-ozempic-or-other-glp-1-drugs-isn-t-cheating/2026-03-28T21:48:20+01:00weekly0.8https://mounjaronews.info/posts/2026-03-28-vanessa-williams-has-had-a-striking-transformation-thanks-to/2026-03-28T21:48:13+01:00weekly0.8https://mounjaronews.info/posts/2026-03-28-tirzepatide-associated-with-lower-risk-of-heart-and-kidney-d/2026-03-28T21:48:05+01:00weekly0.8https://mounjaronews.info/posts/2026-03-28-13-surprising-ways-glp-1s-may-benefit-the-body-according-to-/2026-03-28T07:43:08+01:00weekly0.8https://mounjaronews.info/posts/2026-03-28-glp-1-agonists-could-be-a-global-game-changer-but-need-to-be/2026-03-28T07:43:00+01:00weekly0.8https://mounjaronews.info/posts/2026-03-27-traitement-de-l-obesite-la-chirurgie-fait-mieux-que-les-medi/2026-03-27T07:58:59+01:00weekly0.8https://mounjaronews.info/posts/2026-03-27-orforglipron-vs-tirzepatide-weight-loss-pill-vs-injection/2026-03-27T07:58:52+01:00weekly0.8https://mounjaronews.info/posts/2026-03-27-why-tirzepatide-is-better-than-semaglutide-glp-1-medication-/2026-03-27T07:58:43+01:00weekly0.8https://mounjaronews.info/posts/2026-03-26-ce-duo-de-traitement-a-permis-a-120-femmes-de-perdre-35-de-p/2026-03-26T08:01:06+01:00weekly0.8https://mounjaronews.info/posts/2026-03-26-weight-gain-fears-after-stopping-ozempic-unfounded-cleveland/2026-03-26T08:00:57+01:00weekly0.8https://mounjaronews.info/posts/2026-03-26-improved-heart-and-kidney-outcomes-for-type-1-diabetes-patie/2026-03-26T08:00:48+01:00weekly0.8https://mounjaronews.info/posts/2026-03-24-stopping-glp-1-drugs-may-raise-heart-risks/2026-03-24T07:52:30+01:00weekly0.8https://mounjaronews.info/posts/2026-03-24-india-s-drug-regulator-tightens-surveillance-against-unautho/2026-03-24T07:52:22+01:00weekly0.8https://mounjaronews.info/posts/2026-03-23-eli-lilly-and-company-lly-expands-zepbound-access-as-pricing/2026-03-23T08:01:10+01:00weekly0.8https://mounjaronews.info/posts/2026-03-23-beyond-the-weight-loss-injection-how-this-44-year-old-balanc/2026-03-23T08:01:02+01:00weekly0.8https://mounjaronews.info/posts/2026-03-22-mounjaro-le-traitement-minceur-qui-augmente-la-poitrine-effe/2026-03-22T07:36:44+01:00weekly0.8https://mounjaronews.info/posts/2026-03-22-generic-semaglutide-in-india-and-other-weight-loss-news/2026-03-22T07:36:38+01:00weekly0.8https://mounjaronews.info/posts/2026-03-22-weight-loss-drugs-in-india-ozempic-and-wegovy-alternatives-e/2026-03-22T07:36:29+01:00weekly0.8https://mounjaronews.info/posts/2026-03-21-early-use-of-tirzepatide-after-heart-attack-or-stroke-linked/2026-03-21T07:56:00+01:00weekly0.8https://mounjaronews.info/posts/2026-03-21-heart-benefits-from-glp-1-drugs-fade-after-stopping-study-fi/2026-03-21T07:55:52+01:00weekly0.8https://mounjaronews.info/posts/2026-03-21-glp-1-vision-loss-lawsuits-ozempic-wegovy-and-naion-optic-ne/2026-03-21T07:55:44+01:00weekly0.8https://mounjaronews.info/posts/2026-03-20-lilly-s-triple-g-agonist-succeeds-in-phase-iii-diabetes-tria/2026-03-20T09:05:32+01:00weekly0.8https://mounjaronews.info/posts/2026-03-20-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/2026-03-20T09:05:23+01:00weekly0.8https://mounjaronews.info/posts/2026-03-20-what-happens-after-ozempic-shocked-researchers/2026-03-20T09:05:15+01:00weekly0.8https://mounjaronews.info/posts/2026-03-19-why-did-eli-lilly-stock-slide-6-despite-strong-glp-1-momentu/2026-03-19T09:11:31+01:00weekly0.8https://mounjaronews.info/posts/2026-03-19-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/2026-03-19T09:11:23+01:00weekly0.8https://mounjaronews.info/posts/2026-03-19-semaglutide-vs-tirzepatide-for-weight-loss-us-news-health/2026-03-19T09:11:15+01:00weekly0.8https://mounjaronews.info/posts/2026-03-17-un-medicament-contre-l-obesite-permet-de-perdre-jusqu-a-20-d/2026-03-17T10:10:48+01:00weekly0.8https://mounjaronews.info/posts/2026-03-16-what-happens-when-patients-stop-taking-glp-1-drugs-new-cleve/2026-03-16T10:37:17+01:00weekly0.8https://mounjaronews.info/posts/2026-03-15-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/2026-03-15T08:04:11+01:00weekly0.8https://mounjaronews.info/posts/2026-03-15-compounded-version-of-eli-lilly-glp-1-may-have-impurity-comp/2026-03-15T08:04:02+01:00weekly0.8https://mounjaronews.info/posts/2026-03-15-why-compounded-mounjaro-may-be-riskier-than-you-think-especi/2026-03-15T08:03:54+01:00weekly0.8https://mounjaronews.info/posts/2026-03-14-lilly-says-compounded-tirzepatide-with-added-vitamin-b12-con/2026-03-14T07:59:01+01:00weekly0.8https://mounjaronews.info/posts/2026-03-14-eli-lilly-finds-impurity-in-compounded-tirzepatide-pharmaceu/2026-03-14T07:58:54+01:00weekly0.8https://mounjaronews.info/posts/2026-03-14-in-latest-compounding-clash-lilly-flags-high-levels-of-impur/2026-03-14T07:58:46+01:00weekly0.8https://mounjaronews.info/posts/2026-03-13-lilly-warns-of-impurity-in-compounded-versions-of-tirzepatid/2026-03-13T09:05:39+01:00weekly0.8https://mounjaronews.info/posts/2026-03-13-impurity-in-some-compounded-tirzepatide-potentially-dangerou/2026-03-13T09:05:30+01:00weekly0.8https://mounjaronews.info/posts/2026-03-13-an-open-letter-from-eli-lilly-and-company-warning-of-potenti/2026-03-13T09:05:23+01:00weekly0.8https://mounjaronews.info/posts/2026-03-12-ce-medicament-prescrit-contre-l-obesite-fait-perdre-jusqu-a-/2026-03-12T09:11:46+01:00weekly0.8https://mounjaronews.info/posts/2026-03-12-mounjaro-wegovy-la-prescription-des-traitements-de-l-obesite/2026-03-12T09:11:38+01:00weekly0.8https://mounjaronews.info/posts/2026-03-12-lilly-finds-impurity-in-compounded-version-of-its-weight-los/2026-03-12T09:11:25+01:00weekly0.8https://mounjaronews.info/posts/2026-03-11-which-glp-1-drug-has-the-highest-risk-of-sudden-sight-loss-a/2026-03-11T08:06:24+01:00weekly0.8https://mounjaronews.info/posts/2026-03-11-wegovy-users-have-five-times-greater-risk-of-sudden-sight-lo/2026-03-11T08:06:16+01:00weekly0.8https://mounjaronews.info/posts/2026-03-10-medicaments-anti-obesite-la-prescription-elargie-a-tous-les-/2026-03-10T08:05:56+01:00weekly0.8https://mounjaronews.info/posts/2026-03-10-mounjaro-cleared-for-type-2-diabetes-in-eu-children/2026-03-10T08:05:48+01:00weekly0.8https://mounjaronews.info/posts/2026-03-10-lilly-rewards-ceo-david-ricks-with-36-7m-pay-package-for-202/2026-03-10T08:05:40+01:00weekly0.8https://mounjaronews.info/posts/2026-03-09-two-deaths-reported-to-drug-watchdog-over-potential-link-to-/2026-03-09T09:11:00+01:00weekly0.8https://mounjaronews.info/posts/2026-03-09-eli-lilly-employer-connect-launch-puts-obesity-drug-push-and/2026-03-09T05:18:21+01:00weekly0.8https://mounjaronews.info/posts/2026-03-09-glp-1-drugs-like-ozempic-can-raise-bone-and-tendon-injury-ri/2026-03-09T05:18:14+01:00weekly0.8https://mounjaronews.info/posts/2026-03-08-la-nouvelle-generation-des-medicaments-contre-l-obesite-qub-/2026-03-08T07:52:56+01:00weekly0.8https://mounjaronews.info/posts/2026-03-08-wegovy-saxenda-mounjaro-prescription-elargie-a-tout-medecin-/2026-03-08T07:52:49+01:00weekly0.8https://mounjaronews.info/posts/2026-03-08-what-are-glp-1s-uses-for-weight-loss-diabetes-and-more/2026-03-08T07:52:41+01:00weekly0.8https://mounjaronews.info/posts/2026-03-07-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/2026-03-07T07:51:37+01:00weekly0.8https://mounjaronews.info/posts/2026-03-07-ozempic-wegovy-similar-drugs-what-the-lawsuits-are-about-the/2026-03-07T07:51:28+01:00weekly0.8https://mounjaronews.info/posts/2026-03-06-augmentation-des-ventes-de-medicaments-contre-l-obesite-au-p/2026-03-06T08:02:24+01:00weekly0.8https://mounjaronews.info/posts/2026-03-06-quitting-mounjaro-and-wegovy-jabs-might-actually-leave-you-w/2026-03-06T08:02:15+01:00weekly0.8https://mounjaronews.info/posts/2026-03-06-new-analysis-of-glp-1-drugs-suggests-people-who-stopped-usin/2026-03-06T08:02:06+01:00weekly0.8https://mounjaronews.info/posts/2026-03-05-what-will-change-in-canada-when-generic-ozempic-hits-the-mar/2026-03-05T08:05:31+01:00weekly0.8https://mounjaronews.info/posts/2026-03-05-drugmaker-aspen-targets-mounjaro-approval-in-sub-saharan-afr/2026-03-05T08:05:24+01:00weekly0.8https://mounjaronews.info/posts/2026-03-05-ozempic-like-weight-loss-drugs-may-help-the-heart-recover-af/2026-03-05T08:05:16+01:00weekly0.8https://mounjaronews.info/posts/2026-03-04-la-fda-americaine-met-en-garde-30-societes-de-telesante-cont/2026-03-04T08:03:11+01:00weekly0.8https://mounjaronews.info/posts/2026-03-04-clean-eatz-kitchen-launches-subscription-free-glp-1-meal-pla/2026-03-04T08:03:03+01:00weekly0.8https://mounjaronews.info/posts/2026-03-04-keytruda-hangs-on-to-best-seller-crown-as-glp-1s-gain-ground/2026-03-04T08:02:55+01:00weekly0.8https://mounjaronews.info/posts/2026-03-03-mounjaro-health-benefits-found-to-reverse-one-year-after-sto/2026-03-03T08:06:01+01:00weekly0.8https://mounjaronews.info/posts/2026-03-03-tirzepatide-as-compared-with-semaglutide-for-the-treatment-o/2026-03-03T08:05:53+01:00weekly0.8https://mounjaronews.info/posts/2026-03-03-vital-signs-pharma-s-fastest-growing-drugs/2026-03-03T08:05:46+01:00weekly0.8https://mounjaronews.info/posts/2026-03-02-allurion-announces-partnership-to-offer-combination-therapy-/2026-03-02T09:34:40+01:00weekly0.8https://mounjaronews.info/posts/2026-03-02-weight-loss-drug-linked-to-lower-risk-of-eye-disease-in-pati/2026-03-02T09:34:33+01:00weekly0.8https://mounjaronews.info/posts/2026-03-02-eli-lilly-s-weight-loss-and-diabetes-drug-tops-keytruda-as-w/2026-03-02T09:34:24+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/2026-03-01T18:18:06+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/2026-03-01T18:17:59+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-obesite-remboursement-de-mounjaro/2026-03-01T17:56:41+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-mounjaro-why-medical-experts-say-kenyans-should-be-cautious-/2026-03-01T17:56:32+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-wegovy-vs-mounjaro-8-important-differences/2026-03-01T17:56:23+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-note-d-allurion-technologies-relevee-suite-a-l-approbation-d/2026-03-01T07:54:10+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-que-se-passe-t-il-lorsqu-on-arrete-les-glp-1/2026-03-01T07:54:02+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-mounjaro-eye-side-effects-lawsuit-2026-update/2026-03-01T07:53:54+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-mounjaro-la-has-revise-a-la-hausse-l-amelioration-du-service/2026-03-01T00:18:42+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-c-est-dramatique-ce-medicament-pris-par-des-millions-de-pers/2026-03-01T00:18:34+01:00weekly0.8https://mounjaronews.info/posts/2026-03-01-medicament-anti-obesite-la-haute-autorite-de-sante-donne-son/2026-03-01T00:18:26+01:00weekly0.8https://mounjaronews.info/mentions-legales/2026-01-01T00:00:00Zweekly0.8